Invesco Dynamic Biotechnology & Genome ETF (PBE) Performance

NYSE Arca: PBETotal returns, calendar years, drawdowns and risk since 2005.

PBE total return

Distributions reinvested · as of Oct 23, 2026
YTD
+21.5%
since Dec 31, 2025
1 year
+37.0%
total return
5 years
+6.1%
a year
10 years
+10.1%
a year
Since first price
+9.6%
a year since 2005

PBE trailing returns vs SPY, QQQ, AGG

PBE trailing returns
PeriodPBE total returnPrice onlyS&P 500 (SPY)Nasdaq-100 (QQQ)U.S. bonds (AGG)
1 month+2.5%+2.5%−1.0%−5.0%+0.9%
3 months+9.8%+9.8%+3.2%+1.9%−0.4%
6 months+24.6%+23.3%+7.8%+8.4%−1.5%
YTD+21.5%+20.2%+12.3%+15.1%−1.0%
1 year+37.0%+34.8%+14.4%+15.9%−1.1%
3 years+84.5%+22.7%/yr+80.5%+87.4%+23.3%/yr+101.4%+26.3%/yr+16.6%+5.2%/yr
5 years+34.6%+6.1%/yr+31.5%+79.3%+12.4%/yr+94.0%+14.2%/yr−0.8%−0.2%/yr
10 years+162.6%+10.1%/yr+154.2%+315.9%+15.3%/yr+538.9%+20.4%/yr+14.0%+1.3%/yr
15 years+421.8%+11.6%/yr+396.3%+696.0%+14.8%/yr+1,299.3%+19.2%/yr+32.2%+1.9%/yr
20 years+464.0%+9.0%/yr+433.9%+696.9%+10.9%/yr+1,839.9%+16.0%/yr+79.6%+3.0%/yr
Since inceptionJun 23, 2005+608.0%+9.6%/yr+570.2%———

Total return from adjusted closes (distributions reinvested, before tax). Periods of 3 years or more are also shown annualized. Price only excludes distributions.

Growth of $10,000: PBE vs SPY

PBES&P 500 (SPY)

From Jun 23, 2005: PBE grew to $70,797, SPY to $93,456.

Year-end values with distributions reinvested, no taxes or trading costs. Start: first common trading day of both funds.

PBE returns by calendar year

PBESPY

15 of 20 full years positive. Best 2013 (+62.2%), worst 2008 (−26.7%). 2026 is year to date.

PBE annual returns table

PBE calendar-year returns
YearPBELargest dropSPYQQQAGG
2026YTD+21.5%−11.7%+12.3%+15.1%−1.0%
2025+24.8%−20.3%+17.7%+20.8%+7.2%
2024+1.1%−11.4%+24.9%+25.6%+1.3%
2023+3.7%−22.7%+26.2%+54.9%+5.7%
2022−10.8%−27.1%−18.2%−32.6%−13.0%
2021+1.5%−21.1%+28.7%+27.4%−1.8%
2020+25.7%−30.9%+18.3%+48.6%+7.5%
2019+18.7%−17.5%+31.2%+39.0%+8.5%
2018−0.2%−27.9%−4.6%−0.1%+0.1%
2017+22.3%−14.2%+21.7%+32.7%+3.6%
2016−22.9%−29.7%+12.0%+7.1%+2.4%
2015+1.7%−29.6%+1.2%+9.4%+0.5%
2014+36.3%−18.9%+13.5%+19.2%+6.0%
2013+62.2%−7.8%+32.3%+36.6%−2.0%
2012+13.8%−11.4%+16.0%+18.1%+3.8%
2011−8.4%−26.4%+1.9%+3.4%+7.7%
2010+31.5%−16.0%+15.1%+19.9%+6.4%
2009+21.9%−25.2%+26.4%+54.7%+3.0%
2008−26.7%−40.1%−36.8%−41.7%+7.9%
2007+5.8%−9.4%+5.1%+19.0%+6.6%
2006+2.3%−21.1%+15.8%+7.1%+3.9%

Largest drop = deepest fall from a high within that calendar year.

Calendar-year return vs largest drop within the year

Calendar-year returnLargest drop within the year

Most years include a sizable fall at some point even when the year ends higher.

PBE largest drawdowns

Now 0.8% below the high
PBE largest drawdowns
PeakDeclineBottomRecoveredFallUnderwater
Oct 15, 2007−45.7%Mar 9, 2009Oct 18, 20101.4 years3.0 years
Jul 17, 2015−44.6%Jun 27, 2016Jul 20, 202011 months5.0 years
Feb 8, 2021−37.8%Jun 14, 2022Nov 26, 20251.3 years4.8 years
May 12, 2011−26.4%Aug 8, 2011Jul 2, 20123 months1.1 years
Feb 27, 2006−21.1%Jul 17, 2006Apr 23, 20075 months1.1 years
Feb 24, 2014−18.9%Apr 11, 2014Aug 25, 201446 days6 months

Declines from a closing high (distributions reinvested) of 10% or more. Underwater = time from the peak until the old high was regained.

PBE risk statistics

PBE risk statistics
Statistic3 years5 years10 yearsSince 2005
Annualized return+20.4%+5.9%+9.1%+9.5%
Volatility (annualized)16.8%17.7%19.9%21.2%
Sharpe ratio0.930.210.42—
Sortino ratio1.870.310.67—
Best month+12.4%+12.4%+14.5%+15.6%
Worst month−6.0%−14.7%−14.7%−23.7%
Best 12 months+44.0%+44.0%+58.8%+82.6%
Worst 12 months−6.7%−21.2%−25.4%−36.1%
Positive months61%55%54%56%
Beta vs S&P 5000.690.700.86—
Correlation with S&P 5000.510.620.67—

From monthly total returns. Sharpe and Sortino use 1–3 month T-bills (BIL) as the risk-free rate, so they need history from 2007 on.

PBE rolling returns

PBE rolling returns
Holding periodPeriodsWorstMedianBestPositive
1-year245−36.1%+10.3%+82.6%70%
3-year (a year)221−12.8%+7.3%+39.6%81%
5-year (a year)197−2.9%+6.2%+29.5%98%
10-year (a year)137+1.0%+10.3%+16.3%100%

Every holding period starting at a month-end since 2005. Returns for 3 years and longer are annualized.

PBE performance overview

Invesco Dynamic Biotechnology & Genome ETF (PBE) returned +37.0% over the past year and +10.1% a year over ten years, with distributions reinvested. Since its first recorded price in 2005 it has returned +9.6% a year, turning $10,000 into about $70,797. Over the same year S&P 500 (SPY) returned +14.4%.

The deepest decline was −45.7%, from Oct 15, 2007 to Mar 9, 2009, and it took 1.6 years to get back to the old high. PBE finished 15 of its 20 full calendar years with a gain; the best year was 2013 (+62.2%) and the worst 2008 (−26.7%). Volatility has been 21.2% a year.

Related: PBE chart, PBE holdings, PBE dividends, PBE valuation. See the PBE overview for the latest quote and fund facts.

PBE performance FAQ

What is the PBE return over the past year?

PBE returned +37.0% over the 12 months to October 23, 2026, including reinvested distributions. On price alone it rose 34.8%.

What is the average annual return of PBE?

PBE has returned +6.1% a year over 5 years, +10.1% a year over 10 years, +9.6% a year since June 23, 2005 (total return, distributions reinvested).

How much would $10,000 invested in PBE be worth?

$10,000 invested in PBE at its first recorded close on June 23, 2005 would be worth about $70,797 on October 23, 2026 with distributions reinvested.

What was the worst year for PBE?

The worst calendar year was 2008, with a total return of −26.7%. The best was 2013 at +62.2%.

What is the biggest drawdown of PBE?

The largest peak-to-trough decline was −45.7% between October 15, 2007 and March 9, 2009. It recovered to the old high on October 18, 2010, 1.6 years after the bottom.

How volatile is PBE?

Over the past 3 years PBE had an annualized volatility of 16.8% and a Sharpe ratio of 0.93 (excess return over 1–3 month T-bills per unit of risk).